Purple Footprints
PBAC reviews new treatment
Dec 21 2023
Your opinion is required to help the Pharmaceutical Benefits Advisory Committee (PBAC) evaluate whether a new treatment should be funded for metastatic pancreatic cancer.
Read story ➞
PanKind - 2023 Year in Numbers
Dec 15 2023
Our impact in 2023 is due to the support of our entire community. Thank you
Read story ➞
Impact in Research 2023
Dec 14 2023
An overview of key areas of focus for the PanKind research program in 2023, including exciting developments from our Early Detection Initiative.
Read story ➞